Radical prostatectomy for adenocarcinoma of the prostate: The influence of preoperative and pathologic findings on biochemical disease-free outcome

Urology

Volumn 43, Issue 6, 1994, Pages 828-833

  Zietman, A L ^a   Edelstein, R A ^a   Coen, J J ^a   Babayan, R K ^a   Krane, R J ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BONE SCINTISCANNING; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; ECHOGRAPHY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPHADENECTOMY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; SEMINAL VESICLE; TRANSURETHRAL RESECTION;

ADENOCARCINOMA; COHORT STUDIES; HUMAN; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0028225482     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/0090-4295(94)90144-9     Document Type: Article

References (21)

1. An Assessment of Radical Prostatectomy
2. A Decision Analysis of Alternative Treatment Strategies for Clinically Localized Prostate Cancer
3. The case for no initial treatment of localized prostate cancer.
4. Conservative approaches to the management of localized prostatic cancer
5. Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications
6. Multivariate analysis of factors predicting local relapse after radical prostatectomy—possible indications for postoperative radiotherapy
7. Prostate-specific antigen for staging prior to surgery and for early detection of recurrence after surgery.
8. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.
9. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.
10. The value of serum prostate specific antigen determinations before and after radical prostatectomy.
11. Nonparametric Estimation from Incomplete Observations
12. Radical prostatectomy for stage A adenocarcinoma of the prostate: staging errors and their implications for treatment recommendations and disease outcome.
13. Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer.
14. Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy.
15. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup.
16. Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration.
17. Capsular Penetration in Prostate Cancer. Significance for Natural History and Treatment
18. The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels.
19. Adjuvant radiotherapy after radical prostatectomy: is it indicated?
20. Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate